Latest Breaking News On - Poster number - Page 6 : comparemela.com

EQS-News: Immunic Presents Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis at MSMilan2023: The 9th Joint ECTRIMS-ACTRIMS Meeting

Issuer: Immunic, Inc. / Key word(s): Study results/Conference Immunic Presents Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis at MSMilan2023: The 9th Joint ECTRIMS-ACTRIMS Meeting 11.10.2023 / 12:30 CET/CEST The issuer is solely responsible for.

United statesEdna kaplanPaula schwartzJessica breuRobertj foxDaniel vittRx communications groupNeurological instituteExchange commissionImmunic incMellen centerDistribution servicesPresents data from phaseVidofludimus calciumRelapsing remitting multiple sclerosisSerum neurofilament light chain

Immunic to Participate in Scientific Conferences in October

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for.

United statesNoord hollandBruxelles capitaleDarius jean namdjouGeertr dhaensJessica breuEdna kaplanPaula schwartzFranziska burianekRobertj foxRx communications groupExchange commissionAmsterdam university medical centersMellen centerImmunic incRegulatory affairs operations

EQS-News: Immunic to Participate in Scientific Conferences in October

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Scientific Conferences in October 04.10.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in Scientific Conferences in October NEW YORK, October 4, 2023 – I.

Bruxelles capitaleUnited statesNoord hollandEdna kaplanGeertr dhaensJessica breuRobertj foxFranziska burianekDarius jean namdjouPaula schwartzHead of regulatory affairsRegulatory affairs operationsRx communications groupAmsterdam university medical centersGlobal pharmaceutical regulatory affairs summitNeurologic institute

EQS-News: Immunic, Inc : Immunic to Participate in Scientific Conferences in October

EQS-News: Immunic, Inc : Immunic to Participate in Scientific Conferences in October
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Bruxelles capitaleUnited statesNoord hollandEdna kaplanDarius jean namdjouFranziska burianekRobertj foxPaula schwartzJessica breuGeertr dhaensDistribution servicesExchange commissionBig picture panelGlobal pharmaceutical regulatory affairs summitNeurologic instituteRx communications group

23andMe Announces Poster Presentations on 23ME-00610, an Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer s (SITC) 2023 Annual Meeting

23andMe Announces Poster Presentations on 23ME-00610, an Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer s (SITC) 2023 Annual Meeting
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesSecurities exchangeExchange commissionMe holding coSociety for immunotherapy of cancerAnnual meetingUpdated phaseAnnual meeting regular poster abstractPoster numberExhibit hallsPoster hall hoursDose selectionAdvanced solidSecurities actSecurities exchange act